Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

230 Results

Guidelines and Advice

Recommendations for the Management of Actionable Incidental Findings in the Lung Cancer Screening Pilot for People at High Risk

Status: Current

Apr 2021

Guidelines and Advice

Guidance for the Development of a Provincial Approach to Toxicity Management Summary of Recommendations from the Toxicity Management Advisory Committee

Status: Current
ID: N/A
Version: Final

May 2018

Guidelines and Advice

Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program

Status: Current

Jun 2014

Guidelines and Advice

18F-FET PET Imaging in Brain Tumours

Status: Current
ID: ES PET 20

Apr 2022

Guidelines and Advice

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Status: Current
ID: ES 23-2
Version: N/A

Jun 2020

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Updated

Mar 2025

Guidelines and Advice

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Status: Current
ID: GL-C50-21

Jul 2015

Guidelines and Advice

Contouring Nomenclature - Recommendation Report (Head and Neck Cancer)

Status: Current
ID: GL-C50-12

Feb 2014

Guidelines and Advice

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Status: Current
ID: GL-C50-18

Jan 2015

Guidelines and Advice

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Status: Current
ID: GL END 2-31

Jul 2018

Guidelines and Advice

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Status: Current
ID: GL-C50-17

Jan 2015

Guidelines and Advice

Hereditary Cancer Testing Eligibility Criteria: Version 3.1

Status: Current
Version: 3.1

Oct 2024

Pages